You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
回盛生物(300871.SZ):頭孢泊肟酯片獲新獸藥註冊證書
格隆匯 10-09 18:06

格隆匯10月9日丨回盛生物(300871.SZ)公佈,根據《獸藥管理條例》和《獸藥註冊辦法》規定,經中華人民共和國農業農村部審查,批准武漢回盛生物科技股份有限公司及全資子公司湖北迴盛生物科技有限公司、長沙施比龍動物藥業有限公司等單位申報的“頭孢泊肟酯片”為新獸藥,農業農村部於2022年9月30日公吿並核發《新獸藥註冊證書》(農業農村部公吿第608號)。

頭孢泊肟酯片用於治療犬由金黃色葡萄球菌、中間型葡萄球菌、犬鏈球菌、大腸桿菌、多殺性巴氏桿菌和奇異變形桿菌等引起的皮膚感染(創傷與膿腫)。

公司研製的頭孢泊肟酯片為第三代口服頭孢菌素藥物,具有抗菌譜廣、抗菌作用強、起效迅速、治療效果明顯、安全性高等優勢;該品為帶刻痕片劑,使用劑量易控,使用便捷,適用多種體型犬;產品中使用的風味劑增加犬的可接受度。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account